| Ident. | Authors (with country if any) | Title |
|---|
| 000032 (2013) |
A. H. V. Schapira [Royaume-Uni] ; P. Barone [Italie] ; R. A. Hauser [États-Unis] ; Y. Mizuno [Japon] ; O. Rascol [France] ; M. Busse [Allemagne] ; C. Debieuvre [France] ; M. Fraessdorf [Allemagne] ; Werner Poewe [Autriche] | Success rate, efficacy, and safety/tolerability of overnight switching from immediate‐ to extended‐release pramipexole in advanced Parkinson's disease |
| 000242 (2012) |
Bruno Dubois [France] ; Eduardo Tolosa [Espagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew J. Lees [Royaume-Uni] ; Günther Schumann [Allemagne] ; Emmanuelle Pourcher [Canada] ; Julian Gray [Suisse] ; Gail Thomas [Royaume-Uni] ; Jina Swartz [Royaume-Uni] ; Timothy Hsu [États-Unis] ; Margaret L. Moline [États-Unis] | Donepezil in Parkinson's disease dementia: A randomized, double‐blind efficacy and safety study |
| 000487 (2010) |
Karla Eggert [Allemagne] ; David Squillacote [États-Unis] ; Paolo Barone [Italie] ; Richard Dodel [Allemagne] ; Regina Katzenschlager [Autriche] ; Murat Emre [Turquie] ; Andrew J. Lees [Royaume-Uni] ; Olivier Rascol [France] ; Werner Poewe [Autriche] ; Eduardo Tolosa [Espagne] ; Claudia Trenkwalder [Allemagne] ; Marco Onofrj [Italie] ; Fabrizio Stocchi [Italie] ; Giuseppe Nappi [Italie] ; Vladimir Kostic [Serbie] ; Jagoda Potic [Serbie] ; Evzen Ruzicka [République tchèque] ; Wolfgang Oertel [Allemagne] | Safety and efficacy of perampanel in advanced Parkinson's disease: A randomized, placebo‐controlled study |
| 000547 (2010) |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
| 000667 (2009) |
David Devos [France] | Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease |
| 000784 (2008) |
David Maltête [France] ; Stéphane Derrey [France] ; Nathalie Chastan [France] ; Bertrand Debono [France] ; Emmanuel Gérardin [France] ; Pierre Fréger [France] ; Bruno Mihout [France] ; Jean François Menard [France] ; Didier Hannequin [France] | Microsubthalamotomy: An immediate predictor of long‐term subthalamic stimulation efficacy in Parkinson disease |
| 000807 (2008) |
Sofia Barluenga ; Cuihua Wang ; Jean-Gonzague Fontaine ; Kaïss Aouadi ; Kristin Beebe [États-Unis] ; Shinji Tsutsumi [États-Unis] ; Len Neckers [États-Unis] ; Nicolas Winssinger [France] | Divergent Synthesis of a Pochonin Library Targeting HSP90 and In Vivo Efficacy of an Identified Inhibitor |
| 000808 (2008) |
Sofia Barluenga ; Cuihua Wang ; Jean-Gonzague Fontaine ; Kaïss Aouadi ; Kristin Beebe [États-Unis] ; Shinji Tsutsumi [États-Unis] ; Len Neckers [États-Unis] ; Nicolas Winssinger [France] | Divergent Synthesis of a Pochonin Library Targeting HSP90 and In Vivo Efficacy of an Identified Inhibitor |
| 000B85 (2004) |
Steven Boonen [France] ; Michael R. Mcclung [France] ; Richard Eastell [France] ; Ghada El-Hajj Fuleihan [France] ; Ian P. Barton [France] ; Pierre Delmas [France] | Safety and Efficacy of Risedronate in Reducing Fracture Risk in Osteoporotic Women Aged 80 and Older: Implications for the Use of Antiresorptive Agents in the Old and Oldest Old |
| 000C68 (2003) |
Fiorenzo Gaita [Italie] ; Riccardo Riccardi [Italie] ; Meleze Hocini [France] ; Michel Haissaguerre [France] ; Carla Giustetto [Italie] ; Pierre Jais [France] ; Stefano Grossi [Italie] ; Enrico Caruzzo [Italie] ; Francesca Bianchi [Italie] ; Elena Richiardi [Italie] | Safety and Efficacy of Cryoablation of Accessory Pathways Adjacent to the Normal Conduction System |
| 000C99 (2003) |
Marc Ziegler [France] ; Alexandre Castro-Caldas [Portugal] ; Susanna Del Signore [France] ; Olivier Rascol [France] | Efficacy of piribedil as early combination to levodopa in patients with stable Parkinson's disease: A 6‐month, randomized, placebo‐controlled study |
| 001121 (2000) |
Màté Dàniel Döbrössy [France] ; Michel Le Moal [France] ; Marie-Francoise Montaron [France] ; Nora Abrous [France] | Influence of Environment on the Efficacy of Intrastriatal Dopaminergic Grafts |
| 001160 (2000) |
G. Geraud [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; J. Olesen [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; V. Pfaffenrath [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; P. Tfelt-Hansen [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; R. Zupping [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; H-C Diener [France, Danemark, Allemagne, Estonie, Royaume-Uni] ; R. Sweet [France, Danemark, Allemagne, Estonie, Royaume-Uni] | Comparison of the Efficacy of Zolmitriptan and Sumatriptan: Issues in Migraine Trial Design |
| 001968 (1995) |
M. Bonnet [France] ; I. Serre [France] ; R. Marconi [France] ; Yves Agid [France] ; B. Dubois [France] | A “combined” levodopa test as a useful method for evaluating the efficacy of dopamine agonists: Application to pergolide and bromocriptine |
| 001D67 (1991) |
F. Durif [France] ; E. Jeanneau [France] ; F. Serre-Debeauvais [France] ; D. Deffond [France] ; A. Eschalier [France] ; M. Tournilhac [France] | Relation between plasma concentration and clinical efficacy after sublingual single dose apomorphine in Parkinson's disease |
| 002222 (1984) |
Philippe Coumel [France] ; Jean-François Leclercq [France] ; Patrick Assayag [France] | European experience with the antiarrhythmic efficacy of propafenone for supraventricular and ventricular arrhythmias |
